Sanofi Sa Stock Fundamentals
| SAN Stock | EUR 106.22 0.28 0.26% |
Sanofi SA fundamentals help investors to digest information that contributes to Sanofi SA's financial success or failures. It also enables traders to predict the movement of Sanofi Stock. The fundamental analysis module provides a way to measure Sanofi SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sanofi SA stock.
Sanofi |
Sanofi SA Company Return On Equity Analysis
Sanofi SA's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sanofi SA Return On Equity | 0.12 |
Most of Sanofi SA's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sanofi SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sanofi SA has a Return On Equity of 0.1177. This is 100.49% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on equity for all France stocks is 137.97% lower than that of the firm.
Sanofi SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sanofi SA's current stock value. Our valuation model uses many indicators to compare Sanofi SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sanofi SA competition to find correlations between indicators driving Sanofi SA's intrinsic value. More Info.Sanofi SA is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sanofi SA is roughly 2.11 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sanofi SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sanofi SA's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sanofi Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sanofi SA's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sanofi SA could also be used in its relative valuation, which is a method of valuing Sanofi SA by comparing valuation metrics of similar companies.Sanofi SA is currently under evaluation in return on equity category among its peers.
Sanofi Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0559 | |||
| Profit Margin | 0.18 % | |||
| Operating Margin | 0.24 % | |||
| Current Valuation | 128.44 B | |||
| Shares Outstanding | 1.25 B | |||
| Shares Owned By Insiders | 11.23 % | |||
| Shares Owned By Institutions | 47.20 % | |||
| Price To Earning | 8.63 X | |||
| Price To Book | 1.61 X | |||
| Price To Sales | 2.53 X | |||
| Revenue | 45.39 B | |||
| Gross Profit | 31.7 B | |||
| EBITDA | 13.77 B | |||
| Net Income | 8.37 B | |||
| Cash And Equivalents | 9.72 B | |||
| Cash Per Share | 7.76 X | |||
| Total Debt | 14.86 B | |||
| Debt To Equity | 0.34 % | |||
| Current Ratio | 1.55 X | |||
| Book Value Per Share | 59.70 X | |||
| Cash Flow From Operations | 10.53 B | |||
| Earnings Per Share | 6.66 X | |||
| Price To Earnings To Growth | 1.63 X | |||
| Target Price | 103.6 | |||
| Number Of Employees | 91.57 K | |||
| Beta | 0.41 | |||
| Market Capitalization | 110.83 B | |||
| Total Asset | 124.58 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.04 % | |||
| Five Year Return | 3.86 % | |||
| Net Asset | 124.58 B | |||
| Last Dividend Paid | 3.56 |
About Sanofi SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sanofi SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sanofi SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sanofi SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. Sanofi was incorporated in 1994 and is headquartered in Paris, France. SANOFI operates under Drug ManufacturersGeneral classification in France and is traded on Paris Stock Exchange. It employs 99412 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Sanofi Stock
Sanofi SA financial ratios help investors to determine whether Sanofi Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sanofi with respect to the benefits of owning Sanofi SA security.